import – Lab DB

Pharmaceutical R&D

US Import Tariffs Fail to Deter Biopharma Giants as European Contract Manufacturing Surges for FDA-Approved Drugs

Teuku Ryan Apr 8, 2026 0

The biopharmaceutical industry is demonstrating a significant and counterintuitive trend in 2025, with companies increasingly channeling investments into European-based contract…

US Import Tariffs Fail to Deter Biopharma Giants as European Contract Manufacturing Surges for FDA-Approved Drugs

YOU MAY HAVE MISSED

Merck and Moderna’s cancer vaccine is customized for each patient’s tumor

An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison

ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer

Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage